Abstract
For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.
Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles
Current Cancer Drug Targets
Title: Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Volume: 11 Issue: 2
Author(s): I. Ali
Affiliation:
Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles
Abstract: For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.
Export Options
About this article
Cite this article as:
Ali I., Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives, Current Cancer Drug Targets 2011; 11 (2) . https://dx.doi.org/10.2174/156800911794328457
DOI https://dx.doi.org/10.2174/156800911794328457 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetes Mellitus: Novel Insights, Analysis and Interpretation of Pathophysiology and Complications Management with Imidazole-Containing Peptidomimetic Antioxidants
Recent Patents on Drug Delivery & Formulation Metabolic Obesity: The Paradox Between Visceral and Subcutaneous Fat
Current Diabetes Reviews Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction
Current Pharmaceutical Design Abeta Immunotherapy and Other Means to Remove Amyloid
Current Drug Targets - CNS & Neurological Disorders Angiogenesis Inhibitors: Current & Future Directions
Current Pharmaceutical Design New Approaches to Atherosclerotic Cardiovascular Disease. The Potentialities of Torcetrapib
Recent Patents on Cardiovascular Drug Discovery Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry Antimicrobial Action of Chelating Agents: Repercussions on the Microorganism Development, Virulence and Pathogenesis
Current Medicinal Chemistry Heart Failure Epidemiology: European Perspective
Current Cardiology Reviews Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Endothelial to Mesenchymal Transition in the Cardiogenesis and Cardiovascular Diseases
Current Cardiology Reviews Protective Effect of Annurca Apple Extract Against Oxidative Damage in Human Erythrocytes
Current Nutrition & Food Science Editorial [Hot Topic: New Developments in the Prevention and Treatment of Vascular Disease - 2 Executive (Guest Editors: Manfredi Rizzo and Dimitri P. Mikhailidis)]
Current Pharmaceutical Design Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
Current Cardiology Reviews Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Current Pharmaceutical Design Isotyping the Human TOMM40 Variable-Length Polymorphism by Gene Amplification and Restriction Digest
Current Alzheimer Research Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis
Current Drug Metabolism Massively Parallel Screening of the Receptorome
Combinatorial Chemistry & High Throughput Screening Why is the Incidence of Type 1 Diabetes Increasing?
Current Diabetes Reviews Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma
Current Topics in Medicinal Chemistry